Oldest pages

Jump to navigation Jump to search

Showing below up to 250 results in range #101 to #350.

View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)

  1. ICRP Publication 58‏‎ (15:24, 10 May 2019)
  2. ICRP Publication 57‏‎ (15:25, 10 May 2019)
  3. ICRP Publication 56‏‎ (15:25, 10 May 2019)
  4. ICRP Publication 55‏‎ (15:25, 10 May 2019)
  5. ICRP Publication 54‏‎ (15:26, 10 May 2019)
  6. ICRP Publication 53‏‎ (15:26, 10 May 2019)
  7. ICRP Publication 52‏‎ (15:27, 10 May 2019)
  8. ICRP Publication 51‏‎ (15:27, 10 May 2019)
  9. ICRP Publication 50‏‎ (15:27, 10 May 2019)
  10. ICRP Publication 49‏‎ (15:28, 10 May 2019)
  11. ICRP Publication 48‏‎ (15:28, 10 May 2019)
  12. ICRP Publication 47‏‎ (15:28, 10 May 2019)
  13. ICRP Publication 46‏‎ (15:29, 10 May 2019)
  14. ICRP Publication 45‏‎ (15:29, 10 May 2019)
  15. ICRP Publication 44‏‎ (15:29, 10 May 2019)
  16. ICRP Publication 43‏‎ (15:30, 10 May 2019)
  17. ICRP Publication 42‏‎ (15:30, 10 May 2019)
  18. ICRP Publication 41‏‎ (15:30, 10 May 2019)
  19. ICRP Publication 40‏‎ (15:30, 10 May 2019)
  20. ICRP Publication 39‏‎ (15:31, 10 May 2019)
  21. ICRP Publication 38‏‎ (15:31, 10 May 2019)
  22. ICRP Publication 37‏‎ (15:31, 10 May 2019)
  23. ICRP Publication 36‏‎ (15:31, 10 May 2019)
  24. ICRP Publication 35‏‎ (15:31, 10 May 2019)
  25. ICRP Publication 34‏‎ (15:32, 10 May 2019)
  26. ICRP Publication 33‏‎ (15:32, 10 May 2019)
  27. ICRP Publication 32‏‎ (15:32, 10 May 2019)
  28. ICRP Publication 31‏‎ (15:32, 10 May 2019)
  29. ICRP Publication 30‏‎ (15:33, 10 May 2019)
  30. ICRP Publication 30 (Part 1)‏‎ (15:35, 10 May 2019)
  31. ICRP Publication 30 (Part 2)‏‎ (15:35, 10 May 2019)
  32. ICRP Publication 30 (Part 3)‏‎ (15:36, 10 May 2019)
  33. ICRP Publication 30 (Part 4)‏‎ (15:36, 10 May 2019)
  34. ICRP Publication 30 (Index)‏‎ (15:42, 10 May 2019)
  35. ICRP Publication 30 (Supplement to Part 1)‏‎ (15:43, 10 May 2019)
  36. ICRP Publication 30 (Supplement to Part 2)‏‎ (15:44, 10 May 2019)
  37. ICRP Publication 30 (Supplement A to Part 3)‏‎ (15:44, 10 May 2019)
  38. ICRP Publication 30 (Supplement B to Part 3)‏‎ (15:45, 10 May 2019)
  39. ICRP Publication 29‏‎ (15:46, 10 May 2019)
  40. ICRP Publication 28‏‎ (15:46, 10 May 2019)
  41. ICRP Publication 27‏‎ (15:46, 10 May 2019)
  42. ICRP Publication 26‏‎ (15:46, 10 May 2019)
  43. ICRP Publication 25‏‎ (15:46, 10 May 2019)
  44. ICRP Publication 24‏‎ (15:47, 10 May 2019)
  45. ICRP Publication 23‏‎ (15:47, 10 May 2019)
  46. ICRP Publication 22‏‎ (15:47, 10 May 2019)
  47. ICRP Publication 21‏‎ (15:47, 10 May 2019)
  48. ICRP Publication 20‏‎ (15:47, 10 May 2019)
  49. ICRP Publication 19‏‎ (15:48, 10 May 2019)
  50. ICRP Publication 18‏‎ (15:48, 10 May 2019)
  51. ICRP Publication 17‏‎ (15:48, 10 May 2019)
  52. ICRP Publication 16‏‎ (15:48, 10 May 2019)
  53. ICRP Publication 15‏‎ (15:49, 10 May 2019)
  54. ICRP Publication 14‏‎ (15:49, 10 May 2019)
  55. ICRP Publication 13‏‎ (15:49, 10 May 2019)
  56. ICRP Publication 12‏‎ (15:49, 10 May 2019)
  57. ICRP Publication 11‏‎ (15:50, 10 May 2019)
  58. ICRP Publication 10‏‎ (15:50, 10 May 2019)
  59. ICRP Publication 10A‏‎ (15:50, 10 May 2019)
  60. ICRP Publication 9‏‎ (15:51, 10 May 2019)
  61. ICRP Publication 8‏‎ (15:51, 10 May 2019)
  62. ICRP Publication 7‏‎ (15:51, 10 May 2019)
  63. ICRP Publication 6‏‎ (15:52, 10 May 2019)
  64. ICRP Publication 5‏‎ (15:52, 10 May 2019)
  65. ICRP Publication 4‏‎ (15:52, 10 May 2019)
  66. ICRP Publication 3‏‎ (15:52, 10 May 2019)
  67. ICRP Publication 2‏‎ (15:52, 10 May 2019)
  68. ICRP Publication 1‏‎ (15:53, 10 May 2019)
  69. 1959 Decisions‏‎ (15:54, 10 May 2019)
  70. 1956 Recommendations‏‎ (15:56, 10 May 2019)
  71. 1954 Recommendations‏‎ (15:56, 10 May 2019)
  72. 1950 Recommendations‏‎ (15:57, 10 May 2019)
  73. 1937 Recommendations‏‎ (15:58, 10 May 2019)
  74. 1934 Recommendations‏‎ (15:58, 10 May 2019)
  75. 1931 Recommendations‏‎ (15:58, 10 May 2019)
  76. 1928 Recommendations‏‎ (15:59, 10 May 2019)
  77. ICRP‏‎ (20:10, 4 June 2019)
  78. International Commission on Radiological Protection‏‎ (20:12, 4 June 2019)
  79. ICRP Supporting Guidance 2‏‎ (18:39, 5 June 2019)
  80. Effects of Exposure‏‎ (17:22, 7 June 2019)
  81. System of radiological protection‏‎ (17:47, 10 June 2019)
  82. Objectives of Radiological Protection‏‎ (19:46, 20 June 2019)
  83. Fundamental Principles of Radiological Protection‏‎ (19:46, 20 June 2019)
  84. Exposure Categories and Situations‏‎ (19:46, 20 June 2019)
  85. Dose limits‏‎ (19:47, 20 June 2019)
  86. Cell death‏‎ (13:46, 12 September 2019)
  87. Programmed cell death‏‎ (13:50, 12 September 2019)
  88. Senescence‏‎ (13:53, 12 September 2019)
  89. Bioassay‏‎ (15:40, 12 September 2019)
  90. Medical exposure‏‎ (17:13, 12 September 2019)
  91. Patient entrance reference point‏‎ (17:15, 12 September 2019)
  92. Solar wind‏‎ (17:23, 12 September 2019)
  93. Acceptance test‏‎ (17:24, 12 September 2019)
  94. Accountability‏‎ (17:25, 12 September 2019)
  95. Action Level‏‎ (17:26, 12 September 2019)
  96. Active (red) bone marrow‏‎ (17:26, 12 September 2019)
  97. Adventitious‏‎ (17:27, 12 September 2019)
  98. Aerodynamic diameter‏‎ (17:29, 12 September 2019)
  99. Air-kerma rate constant‏‎ (17:31, 12 September 2019)
  100. Air-kerma, entrance surface‏‎ (17:31, 12 September 2019)
  101. Air-kerma, incident‏‎ (17:32, 12 September 2019)
  102. Air-kerma, product‏‎ (17:33, 12 September 2019)
  103. Alimentary tract transfer factor‏‎ (17:34, 12 September 2019)
  104. Alpha decay‏‎ (17:35, 12 September 2019)
  105. Alveolar-interstitial region‏‎ (17:35, 12 September 2019)
  106. Angiogenesis‏‎ (17:35, 12 September 2019)
  107. Annihilation photons‏‎ (17:36, 12 September 2019)
  108. Annual dose‏‎ (17:36, 12 September 2019)
  109. Area monitoring‏‎ (17:37, 12 September 2019)
  110. Auger transition‏‎ (17:37, 12 September 2019)
  111. Authorization‏‎ (17:38, 12 September 2019)
  112. Authorized limit‏‎ (17:38, 12 September 2019)
  113. Autoimmune disease‏‎ (17:39, 12 September 2019)
  114. Autonomy‏‎ (17:39, 12 September 2019)
  115. Averted dose‏‎ (17:40, 12 September 2019)
  116. Wisdom‏‎ (17:43, 12 September 2019)
  117. Waste disposal‏‎ (17:43, 12 September 2019)
  118. Background dose (rate)‏‎ (18:55, 12 September 2019)
  119. Basal cell‏‎ (18:56, 12 September 2019)
  120. Benthic‏‎ (18:57, 12 September 2019)
  121. Beta-minus decay‏‎ (18:57, 12 September 2019)
  122. Beta-plus decay‏‎ (18:58, 12 September 2019)
  123. Biomedical research volunteer‏‎ (18:58, 12 September 2019)
  124. Bioturbation‏‎ (18:59, 12 September 2019)
  125. Bone marrow‏‎ (18:59, 12 September 2019)
  126. Bradycardia‏‎ (18:59, 12 September 2019)
  127. Branching fraction‏‎ (18:59, 12 September 2019)
  128. Bronchial region‏‎ (19:00, 12 September 2019)
  129. Bystander effect‏‎ (19:00, 12 September 2019)
  130. Qualified expert‏‎ (19:03, 12 September 2019)
  131. Occupational exposure‏‎ (19:07, 12 September 2019)
  132. Orphan source‏‎ (19:07, 12 September 2019)
  133. Oversight‏‎ (19:07, 12 September 2019)
  134. Cardiac arrhythmias‏‎ (19:15, 12 September 2019)
  135. Cardiac valve diseases‏‎ (19:16, 12 September 2019)
  136. Cardiomyopathy‏‎ (19:16, 12 September 2019)
  137. Cardioverter-defibrillator‏‎ (19:16, 12 September 2019)
  138. Chronic exposure‏‎ (19:17, 12 September 2019)
  139. Class SR-0 gases‏‎ (19:17, 12 September 2019)
  140. Class SR-1 gases‏‎ (19:17, 12 September 2019)
  141. Class SR-2 gases‏‎ (19:18, 12 September 2019)
  142. Clearance level‏‎ (19:19, 12 September 2019)
  143. Clonogenic cells‏‎ (19:19, 12 September 2019)
  144. Clonogenic survival‏‎ (19:19, 12 September 2019)
  145. Co-expertise‏‎ (19:19, 12 September 2019)
  146. Colony‏‎ (19:20, 12 September 2019)
  147. Committed effective dose‏‎ (19:20, 12 September 2019)
  148. Committed equivalent dose‏‎ (19:20, 12 September 2019)
  149. Complex tissues‏‎ (19:21, 12 September 2019)
  150. Computed tomography dose index‏‎ (19:21, 12 September 2019)
  151. Connective tissue‏‎ (19:21, 12 September 2019)
  152. Consequential late effects‏‎ (19:21, 12 September 2019)
  153. Constancy test‏‎ (19:21, 12 September 2019)
  154. Contamination‏‎ (19:22, 12 September 2019)
  155. Coronary heart disease‏‎ (19:23, 12 September 2019)
  156. Cost-benefit analysis‏‎ (19:24, 12 September 2019)
  157. Coster-Kronig transition‏‎ (19:25, 12 September 2019)
  158. Curie‏‎ (19:25, 12 September 2019)
  159. Cytokines‏‎ (19:26, 12 September 2019)
  160. Decay constant‏‎ (19:28, 12 September 2019)
  161. Decommissioning‏‎ (19:28, 12 September 2019)
  162. Decontamination‏‎ (19:29, 12 September 2019)
  163. Decontamination factor‏‎ (19:29, 12 September 2019)
  164. Deontological Ethics‏‎ (19:30, 12 September 2019)
  165. Diastasis‏‎ (19:30, 12 September 2019)
  166. Dichotomous‏‎ (19:31, 12 September 2019)
  167. Differentiation‏‎ (19:31, 12 September 2019)
  168. In vivo radiobioassay‏‎ (19:32, 12 September 2019)
  169. Disposal‏‎ (19:33, 12 September 2019)
  170. DNA damage signalling‏‎ (19:33, 12 September 2019)
  171. Dose constraint‏‎ (19:35, 12 September 2019)
  172. Dose criteria‏‎ (19:35, 12 September 2019)
  173. Dose limit‏‎ (19:36, 12 September 2019)
  174. Dose per unit intake coefficient‏‎ (19:37, 12 September 2019)
  175. Dose rate‏‎ (19:38, 12 September 2019)
  176. Dose rate effectiveness factor‏‎ (19:38, 12 September 2019)
  177. Dose-rate effect‏‎ (19:39, 12 September 2019)
  178. Dose-threshold‏‎ (19:40, 12 September 2019)
  179. Early normal tissue responses‏‎ (19:43, 12 September 2019)
  180. Edema‏‎ (19:44, 12 September 2019)
  181. Effect Dose 50‏‎ (19:45, 12 September 2019)
  182. Effective charge number‏‎ (19:46, 12 September 2019)
  183. Effective dose equivalent‏‎ (19:47, 12 September 2019)
  184. Effective half-life‏‎ (19:49, 12 September 2019)
  185. Electron-capture decay‏‎ (19:49, 12 September 2019)
  186. Electrophysiology‏‎ (19:51, 12 September 2019)
  187. Emergency‏‎ (19:52, 12 September 2019)
  188. Emergency exposure situation‏‎ (19:52, 12 September 2019)
  189. Emergency plan‏‎ (19:53, 12 September 2019)
  190. Emergency preparedness‏‎ (19:53, 12 September 2019)
  191. Emergency procedures‏‎ (19:53, 12 September 2019)
  192. Endogeneous excretion‏‎ (19:54, 12 September 2019)
  193. Environmental exposure‏‎ (19:55, 12 September 2019)
  194. Environmental radiation protection‏‎ (19:55, 12 September 2019)
  195. Epithelium‏‎ (19:56, 12 September 2019)
  196. Erythropoietin‏‎ (19:57, 12 September 2019)
  197. Ethics‏‎ (19:58, 12 September 2019)
  198. Exempt waste‏‎ (19:59, 12 September 2019)
  199. Exemption level‏‎ (19:59, 12 September 2019)
  200. Existing exposure situation‏‎ (20:00, 12 September 2019)
  201. Exponential survival curve‏‎ (20:01, 12 September 2019)
  202. Exposure, external or internal‏‎ (20:01, 12 September 2019)
  203. Exposure situation‏‎ (20:02, 12 September 2019)
  204. Habitual mouth breather‏‎ (12:42, 13 September 2019)
  205. Habitual nose breather‏‎ (12:42, 13 September 2019)
  206. Half-life, physical‏‎ (12:43, 13 September 2019)
  207. Hazard‏‎ (12:43, 13 September 2019)
  208. Health Surveillance‏‎ (12:43, 13 September 2019)
  209. Heliosphere‏‎ (12:44, 13 September 2019)
  210. Hierarchical tissues‏‎ (12:44, 13 September 2019)
  211. High level waste‏‎ (12:45, 13 September 2019)
  212. Hormones‏‎ (12:45, 13 September 2019)
  213. Hyperbaric oxygen‏‎ (12:46, 13 September 2019)
  214. Hypertrophic cardiomyopathy‏‎ (12:48, 13 September 2019)
  215. Hypoplasia‏‎ (12:48, 13 September 2019)
  216. Immune system‏‎ (12:49, 13 September 2019)
  217. Incident‏‎ (12:50, 13 September 2019)
  218. Inclusiveness‏‎ (12:50, 13 September 2019)
  219. Individual decontamination‏‎ (12:50, 13 September 2019)
  220. Individual monitoring‏‎ (12:51, 13 September 2019)
  221. Individual-related‏‎ (12:51, 13 September 2019)
  222. Inhalability‏‎ (12:53, 13 September 2019)
  223. Inner bremsstrahlung‏‎ (12:53, 13 September 2019)
  224. Institutional control‏‎ (12:54, 13 September 2019)
  225. Intermediate level waste‏‎ (12:54, 13 September 2019)
  226. Internal conversion electron‏‎ (12:56, 13 September 2019)
  227. Interphase death‏‎ (12:56, 13 September 2019)
  228. Intervention Level‏‎ (12:56, 13 September 2019)
  229. Interventional procedure‏‎ (12:57, 13 September 2019)
  230. Iso-effect plots‏‎ (12:58, 13 September 2019)
  231. Isomers‏‎ (12:58, 13 September 2019)
  232. Isotropic geometry‏‎ (12:58, 13 September 2019)
  233. Itinerant (radiation) worker‏‎ (12:59, 13 September 2019)
  234. Latent time/period or latency interval‏‎ (13:01, 13 September 2019)
  235. Limitation of dose‏‎ (13:01, 13 September 2019)
  236. Lineal energy‏‎ (13:02, 13 September 2019)
  237. Linear-non-threshold model‏‎ (13:03, 13 September 2019)
  238. Low level waste‏‎ (13:08, 13 September 2019)
  239. Lymphatic system‏‎ (13:08, 13 September 2019)
  240. Macrophage colony stimulating factor‏‎ (13:08, 13 September 2019)
  241. Magnetosphere‏‎ (13:09, 13 September 2019)
  242. Member of the public‏‎ (13:10, 13 September 2019)
  243. Mendelian diseases‏‎ (13:10, 13 September 2019)
  244. Mitigation‏‎ (13:10, 13 September 2019)
  245. Multistage tumorigenesis‏‎ (13:11, 13 September 2019)
  246. Myocardial perfusion‏‎ (13:12, 13 September 2019)
  247. Myocardial stress test‏‎ (13:13, 13 September 2019)
  248. Naturally occurring radioactive material‏‎ (13:14, 13 September 2019)
  249. Necrosis‏‎ (13:14, 13 September 2019)
  250. Neurological syndrome‏‎ (13:14, 13 September 2019)

View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)

Retrieved from "http://icrpaedia.org/Special:AncientPages"